STAT — Reporting from the frontiers of health and medicine
- Exclusive STAT Plus: Gene therapy pioneer Kathy High leaves AskBio
- Biotech STAT Plus: Chinese DNA giant’s U.S. affiliate looks to rival Illumina, touting $100 genome and high-power sequencers
- Pharmalot STAT Plus: Pharma loses a court battle in its bid to block states from importing drugs from Canada
- Health Tech Mm-hm, uh-huh: AI-powered medical scribes still can’t understand our conversations
- First Opinion The tyranny of the inbox: What it’s like to be a PCP with OCD
- Pharmalot STAT Plus: Angry at Vertex pricing of cystic fibrosis drugs, families in four countries seek to override patents
- Politics STAT Plus: Former Sen. Richard Burr to join health care practice at law and lobbying firm
- Exclusive STAT Plus: Gene therapy pioneer Kathy High leaves AskBio
- Biotech STAT Plus: Chinese DNA giant’s U.S. affiliate looks to rival Illumina, touting $100 genome and high-power sequencers
- Pharmalot STAT Plus: Pharma loses a court battle in its bid to block states from importing drugs from Canada
- Health Tech Mm-hm, uh-huh: AI-powered medical scribes still can’t understand our conversations
- First Opinion The tyranny of the inbox: What it’s like to be a PCP with OCD
- Pharmalot STAT Plus: Angry at Vertex pricing of cystic fibrosis drugs, families in four countries seek to override patents
- Politics STAT Plus: Former Sen. Richard Burr to join health care practice at law and lobbying firm
Exclusive analysis of biotech, pharma, and the life sciences
- First Opinion Mindstrong’s demise and the future of mental health care
- Politics STAT Plus: The unexpected alliance lobbying for Medicare to pay for new obesity drugs
- Biotech STAT Plus: Chinese DNA giant’s U.S. affiliate looks to rival Illumina, touting $100 genome and high-power sequencers
-
- Biotech STAT Plus: How one biotech investor is changing his calculus now that Medicare can negotiate drug prices
- Pharmalot STAT Plus: Pharma loses a court battle in its bid to block states from importing drugs from Canada
- Health Care ‘They were his best shot. And they failed to help’: Why did EMS workers neglect Tyre Nichols?
- First Opinion Disruptive science is leaping forward, not limping along
- First Opinion The tyranny of the inbox: What it’s like to be a PCP with OCD
- Health Why fentanyl is deadlier than heroin, in a single photo
